This topic contains a solution. Click here to go to the answer

Author Question: Having a benchmark for what to look for if we want to be leaders is about a. Trying to develop ... (Read 49 times)

Lobcity

  • Hero Member
  • *****
  • Posts: 524
Having a benchmark for what to look for if we want to be leaders is about
 
  a. Trying to develop specifically the five major traits in the text
  b. Giving a boss a specific set of traits to look for in potential new hires
  c. Helping individuals see their own traits and decide if these are leadership traits
  d. Specifically determining traits for a particular job promotion

Question 2

Sara is criticized for shifting her management style too much and is known as a leader who
  watches out for herself. She is a
 
  a. 1, 9 leader
  b. 9, 1 leader
  c. Opportunistic leader
  d. Paternalistic leader



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

verrinzo

  • Sr. Member
  • ****
  • Posts: 346
Answer to Question 1

C

Answer to Question 2

C




Lobcity

  • Member
  • Posts: 524
Reply 2 on: Jul 8, 2018
Gracias!


ryhom

  • Member
  • Posts: 366
Reply 3 on: Yesterday
Excellent

 

Did you know?

Certain rare plants containing cyanide include apricot pits and a type of potato called cassava. Fortunately, only chronic or massive ingestion of any of these plants can lead to serious poisoning.

Did you know?

In most climates, 8 to 10 glasses of water per day is recommended for adults. The best indicator for adequate fluid intake is frequent, clear urination.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

Medications that are definitely not safe to take when breastfeeding include radioactive drugs, antimetabolites, some cancer (chemotherapy) agents, bromocriptine, ergotamine, methotrexate, and cyclosporine.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library